Sign up to save your podcasts
Or
Share Measurable disease per FET-PET vs MRI in GBM
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Measurable disease per FET-PET vs MRI in GBM
Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.
View all episodes
By Neuro-Oncology
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.
More shows like Neuro-Oncology: The Podcast
View all
Global News Podcast
7,686 Listeners
Science Weekly
413 Listeners
Freakonomics Radio
32,030 Listeners
The Daily
110,916 Listeners
Up First from NPR
55,879 Listeners
OncLive® On Air
21 Listeners
Lung Cancer Considered
26 Listeners
Neurosurgery Podcast
111 Listeners
The Rest Is History
12,503 Listeners
The Ezra Klein Show
15,316 Listeners
The Weekly Show with Jon Stewart
10,240 Listeners
Pop Culture Parenting
68 Listeners
Glioblastoma aka GBM
25 Listeners
Oncology for the Inquisitive Mind
4 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
38 Listeners